20812-U
ORBO™ 80 Coated Filter
with cassettes unassembled
Synonym(s):
ORBO 80, coated filter for diisocyanates
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NB.24
UNSPSC Code:
41104900
material
glass fiber filter
Quality Level
agency
OSHA 5002
product line
ORBO™
packaging
pkg of 25 ea
technique(s)
active air sampling: suitable
filter O.D.
37 mm
application(s)
air monitoring
environmental
industrial hygiene
storage temp.
2-8°C
General description
ORBO™ 80 Coated Filter, a glass fiber filter coated with 1-(2-pyridyl)piperazine, is generally used for sampling diisocyanates in air.
Legal Information
ORBO is a trademark of Sigma-Aldrich Co. LLC
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
230.0 °F - closed cup
flash_point_c
110 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
H Stalsberg et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 414(5), 415-422 (1989-01-01)
The autopsies of 12 victims from two snow avalanches in North-Norway are reported. Supportive evidence from non-autopsied and surviving victims is included. Consistent autopsy findings were prominent lung oedema, moderate cerebral oedema, extreme contraction of the left ventricle, petechiae in
A Orbo et al.
International journal of oncology, 5(3), 619-625 (1994-09-01)
About 50% of the cases with invasive carcinoma of the uterine cervix occurs before menopause. Cyclic changes of sex steroids may therefore interfere with the ratio between extracellular levels of cGMP and cAMP (cGMP(ex)/cAMP(ex)). This ratio has been proposed as
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine